Home Skinovations Ltd.
11
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ToothWave Calculus Reduction and Accumulation Prevention Study
Role: lead
Safety and Efficacy of the ToothWave Powered Toothbrush for Extrinsic Stain Reduction (Texas)
Role: lead
ToothWave Plaque and Gingivitis Study
Role: lead
Self-selection Study of the Toothwave Toothbrush
Role: lead
Safety and Efficacy of the ToothWave -12 Weeks Calculus Study
Role: lead
Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction
Role: lead
Safety, Efficacy and Usage Compliance of the Silk'n Tightra Device
Role: lead
Silk'n HST Device Usability and Self Selection Study
Role: lead
Clinical Evaluation of Silk'n Glide for Face
Role: lead
Silk'n HST for Wrinkle Reduction - Clinical Study Protocol
Role: lead
Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment
Role: lead
All 11 trials loaded